Phase II evaluation of gefitinib in patients with newly diagnosed grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group study N0074

Kenneth D. Aldape, Karla Ballman, Alfred Furth, Jan. C. Buckner, Caterina Giannini, Peter C. Burger, Bernd W. Scheithauer, Robert B. Jenkins, C. David James, Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance. Journal of Neuropathology and Experimental Neurology. ,vol. 63, pp. 700- 707 ,(2004) , 10.1093/JNEN/63.7.700

Ralf F. Pettersson, A. Jonas Ekstrand, C. David James, V. Peter Collins, V. Peter Collins, Barbara Seliger, Webster K. Cavenee, Genes for Epidermal Growth Factor Receptor, Transforming Growth Factor α, and Epidermal Growth Factor and Their Expression in Human Gliomas in Vivo Cancer Research. ,vol. 51, pp. 2164- 2172 ,(1991)

Towia A. Libermann, Harris R. Nusbaum, Nissim Razon, Richard Kris, Irit Lax, Hermona Soreq, Nigel Whittle, Michael D. Waterfield, Axel Ullrich, Joseph Schlessinger, Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin Nature. ,vol. 313, pp. 144- 147 ,(1985) , 10.1038/313144A0

Angélique Guillaudeau, Karine Durand, Isabelle Pommepuy, Sandrine Robert, Alain Chaunavel, Sylvain Lacorre, Rafaël DeArmas, Sylvie Bourtoumieux, Mounira El Demery, Jean-Jacques Moreau, François Labrousse, Determination of EGFR Status in Gliomas Applied Immunohistochemistry & Molecular Morphology. ,vol. 17, pp. 220- 226 ,(2009) , 10.1097/PAI.0B013E31818DB320

Amy B. Heimberger, Roman Hlatky, Dima Suki, David Yang, Jeff Weinberg, Mark Gilbert, Raymond Sawaya, Kenneth Aldape, Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients. Clinical Cancer Research. ,vol. 11, pp. 1462- 1466 ,(2005) , 10.1158/1078-0432.CCR-04-1737

Ingo K Mellinghoff, Maria Y Wang, Igor Vivanco, Daphne A Haas-Kogan, Shaojun Zhu, Ederlyn Q Dia, Kan V Lu, Koji Yoshimoto, Julie HY Huang, Dennis J Chute, Bridget L Riggs, Steve Horvath, Linda M Liau, Webster K Cavenee, P Nagesh Rao, Rameen Beroukhim, Timothy C Peck, Jeffrey C Lee, William R Sellers, David Stokoe, Michael Prados, Timothy F Cloughesy, Charles L Sawyers, Paul S Mischel, None, Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. The New England Journal of Medicine. ,vol. 353, pp. 2012- 2024 ,(2005) , 10.1056/NEJMOA051918

Martin J. van den Bent, Alba A. Brandes, Roy Rampling, Mathilde C.M. Kouwenhoven, Johan M. Kros, Antoine F. Carpentier, Paul M. Clement, Marc Frenay, Mario Campone, Jean-Francois Baurain, Jean-Paul Armand, Martin J.B. Taphoorn, Alicia Tosoni, Heidemarie Kletzl, Barbara Klughammer, Denis Lacombe, Thierry Gorlia, Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034 Journal of Clinical Oncology. ,vol. 27, pp. 1268- 1274 ,(2009) , 10.1200/JCO.2008.17.5984

Roger Stupp, Warren P. Mason, Martin J. van den Bent, Michael Weller, Barbara Fisher, Martin J.B. Taphoorn, Karl Belanger, Alba A. Brandes, Christine Marosi, Ulrich Bogdahn, Jürgen Curschmann, Robert C. Janzer, Samuel K. Ludwin, Thierry Gorlia, Anouk Allgeier, Denis Lacombe, J. Gregory Cairncross, Elizabeth Eisenhauer, René O. Mirimanoff, Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma The New England Journal of Medicine. ,vol. 352, pp. 987- 996 ,(2005) , 10.1056/NEJMOA043330

Ezra E. W. Cohen, Fred Rosen, Walter M. Stadler, Wendy Recant, Kerstin Stenson, Dezheng Huo, Everett E. Vokes, Phase II Trial of ZD1839 in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Journal of Clinical Oncology. ,vol. 21, pp. 1980- 1987 ,(2003) , 10.1200/JCO.2003.10.051

Daphne A. Haas-Kogan, Michael D. Prados, Tarik Tihan, David A. Eberhard, Nannette Jelluma, Nils D. Arvold, Rachel Baumber, Kathleen R. Lamborn, Ami Kapadia, Mary Malec, Mitchel S. Berger, David Stokoe, Epidermal Growth Factor Receptor, Protein Kinase B/Akt, and Glioma Response to Erlotinib Journal of the National Cancer Institute. ,vol. 97, pp. 880- 887 ,(2005) , 10.1093/JNCI/DJI161